These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1854 related items for PubMed ID: 35276067

  • 21. Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetuses.
    Rajiv P, Cade T, Dean J, Jones GD, Brennecke SP.
    AJOG Glob Rep; 2024 Feb; 4(1):100302. PubMed ID: 38318268
    [Abstract] [Full Text] [Related]

  • 22. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).
    Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Martins JG, Biggio JR, Abuhamad A.
    Am J Obstet Gynecol; 2020 Oct; 223(4):B2-B17. PubMed ID: 32407785
    [Abstract] [Full Text] [Related]

  • 23. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A, Jabak S, De Castro H, Frei L, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [Abstract] [Full Text] [Related]

  • 24. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Barton JR, Woelkers DA, Newman RB, Combs CA, How HY, Boggess KA, Martin JN, Kupfer K, Sibai BM, PETRA (Preeclampsia Triage by Rapid Assay) Trial.
    Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
    [Abstract] [Full Text] [Related]

  • 25. [Preeclampsia: Guidelines for clinical practice from the French College of Obstetricians and Gynecologists].
    Sentilhes L, Schmitz T, Arthuis C, Barjat T, Berveiller P, Camilleri C, Froeliger A, Garabedian C, Guerby P, Korb D, Lecarpentier E, Mattuizzi A, Sibiude J, Sénat MV, Tsatsaris V.
    Gynecol Obstet Fertil Senol; 2024 Jan; 52(1):3-44. PubMed ID: 37891152
    [Abstract] [Full Text] [Related]

  • 26. Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction.
    Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, Tomlinson TM.
    Am J Obstet Gynecol; 2023 Oct; 229(4):447.e1-447.e13. PubMed ID: 37767605
    [Abstract] [Full Text] [Related]

  • 27. Estimated fetal weight at mid-gestation in prediction of pre-eclampsia in singleton pregnancy.
    Frei L, Wright A, Syngelaki A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):335-341. PubMed ID: 34860455
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of fetal growth restriction in a cohort of small-for-gestational-age neonates at term: neonatal and maternal outcomes.
    Pineles BL, Mendez-Figueroa H, Chauhan SP.
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100672. PubMed ID: 35667554
    [Abstract] [Full Text] [Related]

  • 29. Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
    Syngelaki A, Magee LA, von Dadelszen P, Akolekar R, Wright A, Wright D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):367-372. PubMed ID: 35866878
    [Abstract] [Full Text] [Related]

  • 30. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J, Kalafat E, Palmrich P, Pateisky P, Khalil A.
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [Abstract] [Full Text] [Related]

  • 31. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A, Guerby P, Gasse C, Tapp S, Bujold E.
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [Abstract] [Full Text] [Related]

  • 32. Fetal magnetic resonance imaging at 36 weeks predicts neonatal macrosomia: the PREMACRO study.
    Kadji C, Cannie MM, Kang X, Carlin A, Benjou Etchoua S, Resta S, Dütemeyer V, Abi-Khalil F, Mazzone E, Bevilacqua E, Jani JC.
    Am J Obstet Gynecol; 2022 Feb; 226(2):238.e1-238.e12. PubMed ID: 34358479
    [Abstract] [Full Text] [Related]

  • 33. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T, Romero R, Whitten AE, Korzeniewski SJ, Chaemsaithong P, Hernandez-Andrade E, Yeo L, Hassan SS.
    J Matern Fetal Neonatal Med; 2016 Feb; 29(8):1214-28. PubMed ID: 26303962
    [Abstract] [Full Text] [Related]

  • 34. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J, Archer L, Coomar D, Snell KI, Smuk M, Oakey L, Haqnawaz S, Betrán AP, Chappell LC, Ganzevoort W, Gordijn S, Khalil A, Mol BW, Morris RK, Myers J, Papageorghiou AT, Thilaganathan B, Da Silva Costa F, Facchinetti F, Coomarasamy A, Ohkuchi A, Eskild A, Arenas Ramírez J, Galindo A, Herraiz I, Prefumo F, Saito S, Sletner L, Cecatti JG, Gabbay-Benziv R, Goffinet F, Baschat AA, Souza RT, Mone F, Farrar D, Heinonen S, Salvesen KÅ, Smits LJ, Bhattacharya S, Nagata C, Takeda S, van Gelder MM, Anggraini D, Yeo S, West J, Zamora J, Mistry H, Riley RD, Thangaratinam S.
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [Abstract] [Full Text] [Related]

  • 35. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, Thadhani R, Karumanchi SA, Rana S.
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [Abstract] [Full Text] [Related]

  • 36. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH.
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    Chew LC, Osuchukwu OO, Reed DJ, Verma RP.
    ; 2024 01. PubMed ID: 32965939
    [Abstract] [Full Text] [Related]

  • 39. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 40. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, Gascoin G, Gaudineau A, Grangé G, Houfflin-Debarge V, Langer B, Malan V, Marcorelles P, Nizard J, Perrotin F, Salomon L, Senat MV, Serry A, Tessier V, Truffert P, Tsatsaris V, Arnaud C, Carbonne B.
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 93.